Top Markets
#1 GEKKO GEKKO +52.86%
#2 ADO Protocol ADO Protocol +38.44%
#3 Pons Pons +31.32%
#4 Helium Helium +31.23%
#5 TENDIES TENDIES +22.79%
#6 龙虾 (Lobster) 龙虾 (Lobster) +20.33%
#7 o1.exchange o1.exchange +19.33%
#8 Giggle Fund Giggle Fund +18.75%
#9 Main Street Yield Main Street Yield +17.48%
#10 Cysic Cysic +15.13%
Coin of the day
GEKKO GEKKO
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Rankning i aktier #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Aktiekurs
$0.2219522
Senast synkroniserad: 2025-09-11
Marknadsvärde
$1.10B
Förändring (1 dag)
0.04%
Förändring (1 år)
0.17%
Land
CN
Handel Hubei Biocause Pharmaceutical Co., Ltd. (000627)

Kategori

Financial Services
Antal utestående aktier för Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Antal utestående aktier per September 2024: 4.94B
Enligt de senaste finansiella rapporterna och aktiekursen för Hubei Biocause Pharmaceutical Co., Ltd. är det aktuella antalet utestående aktier 4.94B. I slutet av December 2022 hade företaget 4.94B utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Hubei Biocause Pharmaceutical Co., Ltd. (000627) från 2000 till 2026
Utestående aktier vid slutet av varje år
År Utestående aktier Ändra
2026 (TTM) 4.94B -1.45%
2023 5.01B 1.48%
2022 4.94B 0.00%
2021 4.94B 0.00%
2020 4.94B 0.15%
2019 4.93B 0.41%
2018 4.91B 11.14%
2017 4.42B 9.35%
2016 4.04B 194.28%
2015 1.37B -1.67%
2014 1.40B 3.73%
2013 1.35B 2.51%
2012 1.31B -3.09%
2011 1.36B 0.53%
2010 1.35B -0.73%
2009 1.36B 8.23%
2008 1.26B 13.94%
2007 1.10B 0.57%
2006 1.10B 86.84%
2005 586.33M -47.49%
2004 1.12B 0.00%
2003 1.12B 0.00%
2002 1.12B 90.44%
2001 586.33M 0.00%
2000 586.33M 0.00%
Utestående aktier för liknande företag eller konkurrenter
Företag Utestående aktier Skillnad Land
China Life Insurance Company Limited China Life Insurance Company Limited
China Life Insurance Company Limited
601628.SS
 28.27B 472.09%
CN
AIA Group Limited AIA Group Limited
AIA Group Limited
1299.HK
 10.42B 110.92%
HK
Manulife Financial Corporation Manulife Financial Corporation
Manulife Financial Corporation
MFC.TO
 - -
CA
Fubon Financial Holding Co., Ltd. Fubon Financial Holding Co., Ltd.
Fubon Financial Holding Co., Ltd.
2881.TW
 - -
TW
MetLife, Inc. MetLife, Inc.
MetLife, Inc.
MET.US
 - -
US